All stories tagged :

Sample Category Title

China’s time-honored commercial port city Wenzhou to facilitate dialogue between East...

admin
Pr Newswire

TraceLink MINT Awarded 2024 Supply Chain Visibility Solution of the Year...

admin
Pr Newswire

ZKH Group Limited Announces US$50 Million Share Repurchase Program

admin
Pr Newswire

NaaS Technology Inc. Announces Completion of ADS Ratio Change

admin
People

Australia E-commerce Market Databook 2024: Opportunities, Shares, Consumer Attitude & Behaviour...

admin
People

Germany E-commerce Market Report 2024-2028: Major Verticals, Market Share by Key...

admin
People

Skin Health Foods Market Report 2024: Analysis by Indication, Region and...

admin
Pr Newswire

Opus Genetics Announces $1.7 Million in Project-based Funding from the Foundation...

admin
Pr Newswire

Umoja Biopharma Announces Publication in Blood Highlighting Successful Generation of In...

admin
Pr Newswire

Provectus Biopharmaceuticals Announces Investor Webinar for 2024 Annual Meeting of Stockholders

admin
Pr Newswire

Araris Biotech AG Appoints Dr. Ulf Grawunder to Scientific Advisory Board

admin

Featured

Pr Newswire

Harrow Announces Closing of Acquisition of Melt Pharmaceuticals

admin
Pr Newswire

Can-Fite: 9-Year Survival with Complete Cure in an Advanced Liver Cancer...

admin
Pr Newswire

Aiomics Supports Independent Research at Charité to Advance Evidence-Based Clinical Documentation

admin
Pr Newswire

The Medical Stories in the War: the Spirit of Internationalism with...

admin
admin

Harrow Announces Closing of Acquisition of Melt Pharmaceuticals

NASHVILLE, Tenn., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that it has completed the acquisition of Melt Pharmaceuticals, Inc. (Melt), a clinical-stage pharmaceutical company pioneering non-opioid, non-IV therapies for sedation for medical...